Recalls & Warnings September 19, 2018 Seller of Curcumin, Garcinia, Glucosamine and More Warned for Manufacturing Violations On September 7, 2018, the FDA issued a warning letter to Best Nutrition Products, Inc
Superior and Sustained Performance: Arthramid achieves 80-85% efficacy across multiple peer-reviewed studies Long-lasting Results: Clinical studies demonstrate sustained efficacy up to 2 years post-treatment Evidence-Based Efficacy: Double-blinded controlled studies confirm Arthramid outperforms triamcinolone steroid and hyaluronic acid Proven Safety Profile: Histopathology studies confirm successful joint integration and biocompatibility Robust Research Foundation: Results validated across six independent peer-reviewed studies spanning multiple research teams and geographical locations Unlike many joint treatments on the market, Arthramid is backed by a growing body of robust, real-world research, not just anecdotal outcomes
Consumers may also be left to determine dosing and monitor side effects on their own
The released hormone then activates androgen receptors throughout the body to drive nitrogen retention, lean tissue accrual, red blood cell production, and other hallmark androgenic processes